Potential barrier against spread of HPV
Scientists of the University of Tartu Institute of Technology have found a way to use bioluminescence to monitor the growth of the human papillomavirus (HPV) and effects different drugs have on the virus. The method can be used to develop new medicines.
10.02.2017, Riin AljasPM
Leading pharmaceutical company looking toward Lithuania
Estonia's largest pharmaceuticals manufacturer, generic veterinary drug maker Interchemie, has been fighting the State Agency of Medicines over sales permits for a long time and has now turned its gaze toward Lithuania.
07.02.2017, Adele JohansonPM
Methadone – best option for poor Estonia
Methadone might be the only thing drug addicts and policemen agree about – both are critical regarding the distribution of it to addicts. As psychiatrist says it's not the substance that is a problem, rather its African style handouts.
03.03.2016, Madis VaikmaaPM
Effective cure evasive due to random responsibility
A World Bank analysis ordered by Estonian Health Insurance Fund says we lack integrated approach to patients – due to ailing cooperation between family doctors and medical specialists, treatment is often insufficient; once home after being hospitalised, people with acute disease conditions may be left alone with their troubles.
25.03.2015, Marina LohkPM
Good terrorists trained in Tallinn lab
In Mustamäe, Tallinn, training is provided to blood cells acquired from Italian cancer patients during clinical trials so that, when back home, these may point out intestine cancer cells to sick organisms – the latter thus able to fight these more effectively.
15.01.2015, Anneli AmmasPM
Youth in Rakvere ravaged with drugs
Since September, Rakvere has seen nine young people hospitalised – probably by smoking synthetic cannabis aka spice.
20.11.2014, Tiina KaukverePM
On value of solidarity in healthcare
Health Insurance Fund (HIF) chief executive Tanel Ross ponders the topic raised by healthcare expert Ain Aaviksoo: is Estonian version of financing healthcare obsolete and in need of greater patient participation and responsibility? Is it right to redistribute healthy people’s money to those that are sick?
11.07.2014, Liis VelskerPM
Suspects shun showdown with doping doc
Committee called to investigate claims by Vitali Bernatski thinks Estonia does have other doping dealing doctors.
04.06.2014, Peep PahvPM
Defying critics, temporary pharmacy limit destined to come
New pharmacies order is urgently needed, by June. According to Chancellor of Justice, however, transition period with limits is unconstitutional.
14.05.2014, Karin KangroPM
Pharmacies face prescription of temporary stricture
Today, social commission of the Riigikogu sits down to decide whether to impose temporary regulations for 1.5 years following the removal of limitations to opening new pharmacies, so as to curb mass establishing of pharmacies in towns and closure of those in the countryside.
08.05.2014, Karin KangroPM
Glaxosmithkline Estonia boosts profit 3.7 pct on year
The profit of the Estonian medicines seller Glaxosmithkline Eesti OU climbed 3.7 percent to 1.3 million euros and sales 3.3 percent to 30.9 million euros in 2012 compared with 2011.
Estonia: Kristjan Vilosius to take over as CEO of medicines wholesaler Magnum
The chairman of the management board of the Estonian medicines wholesaler Magnum, Leon Jankelevitsh, is leaving on July 3 and board member and CFO Kristjan Vilosius will step into his shoes.
Pharma firm takes apothecaries to illicit trip
Medicament makers are forbidden from giving gifts to prescribers or sellers of drugs. The latter are forbidden from accepting the gifts.
24.04.2013, Hanneli RudiPM
Estonian parlt passes amendment to allow remote sale of medicines
The Estonian parliament on Wednesday passed in the third reading an amendment to the Medicinal Products Act that allows pharmacies to conduct remote sales of medicines.
Volume of Estonia's medicines market grows 9 pct on year in Q4
In all 58.2 million euros' worth of medicines used on humans were sold in Estonia in the final quarter of last year, 9 percent more than during the same period in 2011, the Estonian State Agency of Medicines said.